Good morning,
Last year, Priyanka Jain found herself on a mission.
The head of product at New York City-based Pymetrics, an Inc. 5000 company that builds algorithms to fight bias in hiring, was reading about the health research gap between men and women. In 1977, she learned, the FDA actually banned most women from early clinical trials for non-life threatening diseases--guidance that wasn’t reversed until 1993. Nearly 30 years later, much more is still known about men’s health than women’s health.
Jain was accustomed to using data to solve systemic issues. So, she thought, why not apply that skill to this new problem? To her, doctors and patients don’t know enough about the vaginal microbiome, which refers to the family of microorganisms in the vagina. It can be linked to health outcomes like STIs, preterm births, precancerous cervix lesions, and yeast infections. The vaginal microbiome, "causes so much day-to-day suffering and has these crazy ramifications for overall female health," Jain tells Inc. "And yet, as women, we have no access to that information on our own bodies."
Her New York City-based startup Evvy, which offers expansive at-home testing for the vaginal microbiome, was born. Read our story to learn how Jain reframed what was thought of as a niche health issue--and discovered a business opportunity with massive potential. |
0 Comments:
Post a Comment